drugset / Trial / NCT02757729

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis

NCT02757729

Phase 2 Completed 192 enrolled Amorepacific Corporation
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a phase 2 study to investigate the safety and efficacy of PAC-14028 cream in Atopic Dermatitis patients.

Timeline

Start
2015-10
Primary completion
2016-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject PAC-14028 Unknown 0.1 % Topical
Subject PAC-14028 Unknown 0.3 % Topical
Subject PAC-14028 Unknown 1 % Topical

Indications